Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LMND
LMND logo

LMND Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Lemonade Inc (LMND) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
61.020
1 Day change
-2.66%
52 Week Range
99.900
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Lemonade Inc (LMND) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's strong revenue growth, strategic partnership with Tesla, and positive analyst upgrades suggest significant long-term potential despite current losses.

Technical Analysis

The MACD is positive and contracting (1.786), indicating bullish momentum. RSI is neutral at 64.009, and moving averages are converging, suggesting a potential breakout. The stock is trading near its pivot level of 62.211, with resistance at 68.247 and support at 56.176.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
4

Positive Catalysts

  • Strategic partnership with Tesla for autonomous vehicle insurance, offering a first-mover advantage.

  • Morgan Stanley upgrade to Overweight with an $85 price target.

  • Revenue growth of 53.29% YoY in Q4

  • Expansion into first-time buyer markets and autonomous insurance products.

Neutral/Negative Catalysts

  • Net income dropped by -27.67% YoY in Q4

  • EPS declined by -30.95% YoY, reflecting ongoing profitability challenges.

  • Competitive pressures in the insurance market, as noted by analysts.

Financial Performance

In Q4 2025, revenue increased by 53.29% YoY to $228.1M, showcasing strong growth. However, net income fell to -$21.7M (-27.67% YoY), and EPS dropped to -0.29 (-30.95% YoY), indicating profitability issues.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst sentiment is positive, with Morgan Stanley upgrading the stock to Overweight and raising the price target to $85, citing the Tesla partnership as a growth driver. Truist initiated coverage with a Buy rating and a $98 price target, highlighting Lemonade's AI-driven cost advantages. However, some analysts remain cautious about profitability and competition.

Wall Street analysts forecast LMND stock price to rise
6 Analyst Rating
Wall Street analysts forecast LMND stock price to rise
2 Buy
3 Hold
1 Sell
Hold
Current: 62.680
sliders
Low
40
Averages
77.6
High
98
Current: 62.680
sliders
Low
40
Averages
77.6
High
98
Morgan Stanley
Equal Weight -> Overweight
upgrade
$80 -> $85
AI Analysis
2026-03-17
Reason
Morgan Stanley
Price Target
$80 -> $85
AI Analysis
2026-03-17
upgrade
Equal Weight -> Overweight
Reason
Morgan Stanley upgraded Lemonade (LMND) to Overweight from Equal Weight with a price target of $85, up from $80. The company's partnership with Tesla (TSLA) "represents an important first step" and gives Lemonade first-mover advantage in data analysis and on-the-ground experience, the analyst tells investors in a research note. Morgan Stanley says that while Lemonade is offering a 50% discount on auto insurance when full self-driving is engaged in Tesla vehicles, the company is maintaining underwriting discipline based on the quotes it viewed. It expects Lemonade to expand its autonomous exposure, driving the scale needed to "meaningfully improve" its long-term earnings profile.
Keefe Bruyette
Underperform
maintain
$40 -> $44
2026-02-24
Reason
Keefe Bruyette
Price Target
$40 -> $44
2026-02-24
maintain
Underperform
Reason
Keefe Bruyette raised the firm's price target on Lemonade to $44 from $40 and keeps an Underperform rating on the shares. 30%+ growth, sustained low loss ratios, and efficient customer acquisition spend could be "challenging" to achieve in synchrony with intensifying competition, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for LMND
Unlock Now

People Also Watch